FRANKLYN G PRENDERGAST Insider Trading $NBSE NeuBase Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FRANKLYN G PRENDERGAST.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FRANKLYN G PRENDERGAST. FRANKLYN G PRENDERGAST is Director in LILLY ELI & CO ($LLY) and Director in NeuBase Therapeutics, Inc. ($OHRP) and Director in CANCER GENETICS, INC ($CGIX) and Director in Lantern Pharma Inc. ($LTRN).
FRANKLYN G PRENDERGAST in NeuBase Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FRANKLYN G PRENDERGAST: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 11 2020
$NBSE Market Capitalization: $48.55M
$NBSE Previous Close: $1.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of FRANKLYN G PRENDERGAST in NeuBase Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, LLY, LTRN, NBSE, CGIX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11 2020 | OHRP | NeuBase Therapeuti ... | PRENDERGAST FRANKLYN G | Director | Option Exercise | A | 8.80 | 14,634 | 128,779 | 14,634 | |
| Jul 16 2019 | OHRP | NeuBase Therapeuti ... | PRENDERGAST FRANKLYN G | Director | Option Exercise | A | 5.39 | 227,330 | 1,225,309 | 227,330 | |
| Jul 16 2019 | OHRP | NeuBase Therapeuti ... | PRENDERGAST FRANKLYN G | Director | Option Exercise | A | 5.39 | 227,330 | 1,225,309 | 227,330 |
Page: 1